Inventor

SCHULZ GREGOR

DE9 patents

⚠️ This page may combine multiple inventors who share the name “SCHULZ GREGOR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OSTERROTH FRANK

2 patents

US9289509B2Mar 22, 2016

Uses of immunoconjugates targeting CD138

OSTERROTH FRANK10 citations79

US9995733B2Jun 12, 2018

Agents for treating disease

OSTERROTH FRANK1 citations47

KRAUS ELMAR

2 patents

US9221914B2Dec 29, 2015

Agents targeting CD138 and uses thereof

KRAUS ELMAR6 citations69

US9387261B2Jul 12, 2016

Immunoconjugates targeting CD138 and uses thereof

KRAUS ELMAR4 citations68

SCRIPPS CLINIC RES

1 patent

US4675287AJun 23, 1987

Monoclonal antibody directed to human ganglioside GD2

SCRIPPS CLINIC RES57 citations94

BIOTEST AG

1 patent

US10117932B2Nov 6, 2018

Uses of immunoconjugates targeting CD138

BIOTEST AG7 citations80

SCHULZ GREGOR

1 patent

US9011864B2Apr 21, 2015

Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates

SCHULZ GREGOR19 citations78

AIGNER SILKE

1 patent

US9550831B2Jan 24, 2017

Method for treating psoriasis

AIGNER SILKE1 citations43

GERMER MATTHIAS

1 patent

US9512226B2Dec 6, 2016

Agent for treating disease

GERMER MATTHIAS0 citations42